Showing results (151-160 of 214) with videos related to
Sort By:
Pageof 22
The Journal of Allergy and Clinical Immunology|February 14, 2002
Direct and indirect costs of asthma to an employerHoward G Birnbaum, William E Berger, Paul E Greenberg, et al.The Journal of Pain|June 6, 2006
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic painEric Q Wu, Howard G Birnbaum, Milena N Mareva, et al.Journal of Occupational and Environmental Medicine|February 6, 2010
Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United StatesHoward G Birnbaum, Rym Ben-Hamadi, David Kelley, et al.Parkinsonism & Related Disorders|December 20, 2011
Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's diseaseA Kaltenboeck, S J Johnson, M R Davis, et al.Applied Health Economics and Health Policy|June 13, 2014
Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims dataJ Bradford Rice, Noam Y Kirson, Amie Shei, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 5, 2009
Asthma severity categorization using a claims-based algorithm or pulmonary function testingH G Birnbaum, J I Ivanova, A P Yu, et al.Current Medical Research and Opinion|April 2, 2005
Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000Howard G Birnbaum, Ronald C Kessler, Sarah W Lowe, et al.Journal of Neuroscience Research|May 15, 1996
Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAEG Birnbaum, L Kotilinek, P Schlievert, et al.Current Medical Research and Opinion|August 3, 2007
Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record dataAndrew P Yu, Eric Q Wu, Howard G Birnbaum, et al.Journal of Managed Care & Specialty Pharmacy|September 25, 2015
Characteristics of High-Cost Patients Diagnosed with Opioid AbuseAmie Shei, J Bradford Rice, Noam Y Kirson, et al.Pageof 22